PRCH vs CURI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 10, 2026

PRCH

45.1
AI Score
VS
It's a Tie!

CURI

45.1
AI Score

Investment Advisor Scores

PRCH

45score
Recommendation
HOLD

CURI

45score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric PRCH CURI Winner
Revenue 262.00M 38.41M PRCH
Net Income 890,000 7.55M CURI
Net Margin 0.3% 19.7% CURI
Operating Income 7.70M 7.64M PRCH
ROE -7.5% 18.2% CURI
ROA 0.1% 11.2% CURI
Total Assets 818.99M 67.47M PRCH
Current Ratio 1.45 0.78 PRCH

Relative Price Performance (Last 90 Days)

PRCH 1M: +1.8% · 3M: +69.2% CURI 1M: -5.0% · 3M: +2.3%

Current Technical Phase

PRCH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 49.7 · Price: $16.45

CURI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 46.7 · Price: $2.66

Fundamentals Snapshot

Metric PRCH CURI
Market Cap
Forward P/E 67.8 8.6
Trailing P/E
Revenue (TTM)
Revenue Growth 0.1% 0.2%
Gross Margin 0.7% 0.6%
Operating Margin 0.0% 0.4%
EPS -0.13 -0.01
Dividend Yield 0.13%

Frequently Asked Questions

Based on our detailed analysis, PRCH and CURI are evenly matched, both winning 4 key financial metrics each. This is a close call that depends on your specific investment goals.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.